Alternative pre-approved and novel therapies for the treatment of anthrax
Abstract Background Bacillus anthracis, the causative agent of anthrax, is a spore forming and toxin producing rod-shaped bacterium that is classified as a category A bioterror agent. This pathogenic microbe can be transmitted to both animals and humans. Clinical presentation depends on the route of...
Main Authors: | Breanne M. Head, Ethan Rubinstein, Adrienne F. A. Meyers |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2016-11-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12879-016-1951-y |
Similar Items
-
Anthrax Toxins in Context of Bacillus anthracis Spores and Spore Germination
by: Christopher K. Cote, et al.
Published: (2015-08-01) -
Laboratory diagnostic methods and reported outbreaks of anthrax in Ethiopia
by: Abebe Olani, et al.
Published: (2020-04-01) -
Anthrax Toxin Characterization
by: Jiří Patočka, et al.
Published: (2002-01-01) -
Prophylaxis Against Anthrax
by: Miroslav Špliňo, et al.
Published: (2002-01-01) -
Inhibitory Effects of a Reengineered Anthrax Toxin on Canine and Human Osteosarcoma Cells
by: Jonathan Mackowiak da Fonseca, et al.
Published: (2020-09-01)